Abstract/References

Maternal septic shock due to Acinetobacter lwoffii infection:a case report

Hirotaka Isogami, Misa Sugeno, Karin Imaizumi, Toma Fukuda, Norihito Kamo, Shun Yasuda, Akiko Yamaguchi, Keiya Fujimori

Author information
  • Hirotaka Isogami

    Department of Obstetrics and Gynecology, Fukushima Medical University School of Medicine

  • Misa Sugeno

    Department of Obstetrics and Gynecology, Fukushima Medical University School of Medicine

  • Karin Imaizumi

    Department of Obstetrics and Gynecology, Fukushima Medical University School of Medicine

  • Toma Fukuda

    Department of Obstetrics and Gynecology, Fukushima Medical University School of Medicine

  • Norihito Kamo

    Department of Obstetrics and Gynecology, Fukushima Medical University School of Medicine

  • Shun Yasuda

    Department of Obstetrics and Gynecology, Fukushima Medical University School of Medicine

  • Akiko Yamaguchi

    Department of Obstetrics and Gynecology, Fukushima Medical University School of Medicine

  • Keiya Fujimori

    Department of Obstetrics and Gynecology, Fukushima Medical University School of Medicine

Abstract

The incidence of Acinetobacter infections has increased in recent years. Acinetobacter infections are resistant to most antibiotics and can be found in hospitalized patients. Pregnancies complicated by severe sepsis or septic shock are associated with a higher rate of preterm labor and delivery, fetal infection, and operative delivery. This case report describes septic shock due to Acinetobacter lwoffii infection in the 31st week of gestation. A 47-year-old woman, with a gestation of 31 weeks and one day, presented with a fever, and signs of bacterial infection on laboratory tests. Although the patient was started on tazobactam/piperacillin, she went into septic shock, and was transferred to our hospital. Cesarean section was performed at a gestation of 31 weeks and 4 days because of severe maternal pneumonia and non-reassuring fetal status. A. lwoffii was detected in blood cultures collected at the previous hospital, and susceptibility to piperacillin and meropenem to A. lwoffii was confirmed. The pneumonia responded to antibiotic treatment and there were no findings of infection in the neonate. Maternal sepsis is an infrequent but important complication, causing significant maternal and fetal morbidity and fetal and neonatal mortality; therefore, early antibiotic therapy is required to improve the clinical outcome.

The cintent of reseach paper

References

1. He M, Kostadinov S, Gundogan F, Struminsky J, Pinar H, Sung CJ. Pregnancy and perinatal outcomes associated with Acinetobacter baumannii infection. AJP Rep, 3:51-56, 2013.


2. Fournier PE, Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis, 42:692-699, 2006.


3. Neonakis IK, Spandidos DA, Petinaki E. Confronting multidrug-resistant Acinetobacter baumannii: a review. Int J Antimicrob Agents, 37:102-109, 2011.


4. Falagas ME, Bliziotis IA, Siempos II. Attributable mortality of Acinetobacter baumannii infections in critically ill patients:a systematic review of matched cohort and case-control studies. Crit Care, 10:R48, 2006.


5. Gordon NC, Wareham DW. Multidrug-resistant Acinetobacter baumannii:mechanisms of virulence and resistance. Int J Antimicrob Agents, 35:219-226, 2010.


6. Cantwell R, Clutton-Brock T, Cooper G, et al. Saving mothers’ lives:reviewing maternal deaths to make motherhood safer:2006-08. The Eighth Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG, 118 Suppl 1:1-203, 2011.


7. Aivazova V, Kainer F, Friese K, Mylonas I. Acinetobacter baumannii infection during pregnancy and puerperium. Arch Gynecol Obstet, 281:171-174, 2010.


8. Ku SC, Hsueh PR, Yang PC, Luh KT. Clinical and microbiological characteristics of bacteremia caused by Acinetobacter lwoffii. Eur J Clin Microbiol Infect Dis, 19:501-505, 2000.


9. Domingo P, Munoz R, Frontera G, Roser P, Martinez E. Community-acquired pneumonia due to Acinetobacter lwoffii in a patient infected with the human immunodeficiency virus. Clin Infect Dis, 20:205-206, 1995.


10. Seema M, Madhu S, Aparna Y, Kiran B, Uma C. Acinetobacter lwoffii an emerging pathogen in neonatal ICU. Infect Disord Drug Targets, 15:184-188, 2015.


11. Barton JR, Sibai BM. Severe sepsis and septic shock in pregnancy. Obstet Gynecol, 120:689-706, 2012.


12. Knowles SJ, O'Sullivan NP, Meenan AM, Hanniffy R, Robson M. Maternal sepsis incidence, etiology and outcome for mother and fetus:a prospective study. BJOG, 122(5):663-671, 2015.


13. Morgan J, Roberts S. Maternal sepsis. Obstet Gynecol Clin North Am, 40:69-87, 2013.


14. Bamfo JE. Managing the risks of sepsis in pregnancy. Best Pract Res Clin Obstet Gynaecol, 27:583-595, 2013.


15. Cordioli RL, Cordioli E, Negrini R, Silva E. Sepsis and pregnancy:do we know how to treat this situation? Rev Bras Ter Intensiva, 25:334-344, 2013.


16. Guinn DA, Abel DE, Tomlinson MW. Early goal directed therapy for sepsis during pregnancy. Obstet Gynecol Clin North Am, 34:459-479, 2007.


17. Lucas DN, Robinson PN, Nel MR. Sepsis in obstetrics and the role of the anesthetist. Int J Obstet Anesth, 21:56-67, 2012.


18. Gilroy RJ, Mangura BT, Lavietes MH. Rib cage and abdominal volume displacements during breathing in pregnancy. Am Rev Respir Dis, 137:668, 1988.

Figures